External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASRM 2024

We will be contributing to topics related to
-
05:45 PM
Duration 90mins Denver, Colorado
Anti-Müllerian hormone to determine polycystic ovarian morphology: a sub-analysis of the APHRODITE study in an Asian population
Joop Laven
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins Denver, Colorado
Polycystic Ovary Syndrome risk algorithm (PriskA): a pilot study
Joop Laven
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Access the daily report to view Today's summary of Roche

Sign up or login to unlock the full suite of MEDICALLY features